Nanofiber Therapeutics

Erscheinungsjahr 2025
ISBN: 978-0-443-27745-0
Verlag: Elsevier Inc

Buch, Englisch, 382 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 656 g

Nanofiber Therapeutics: Revolutionizing Cancer and Inflammation Management is a comprehensive resource designed to enrich knowledge, catalyze scientific advancements, empower patients, and inform policy decisions in nanomedicine. This book leverages the transformative potential of nanotechnology to combat cancer and inflammation, two of the most challenging health conditions today. The book explores the revolutionary potential of nanofiber-based therapeutics, aiming to develop innovative solutions that overcome existing treatment limitations and improve patient outcomes. It bridges the gap between basic scientific research and clinical application, synthesizing the latest advancements in nanofiber technology with insights from preclinical and clinical studies. Covering every facet of nanofiber therapies—from design and production to clinical applications—the book offers a comprehensive overview. It aims to educate healthcare professionals, researchers, policymakers, patients, and the public about the potential of nanofiber therapeutics, empowering stakeholders with the knowledge needed for informed decision-making and interdisciplinary collaboration. By highlighting cutting-edge research and technological innovations, this book inspires scientific curiosity and further research in the field. It fills a gap in the existing literature, laying the groundwork for future research and development, and driving advancements that could transform cancer and inflammation treatment.

Autoren/Hrsg.

Mishra, Neeraj

Rath, Goutam

Singh, Arun Kumar

Fachgebiete

• Naturwissenschaften Biowissenschaften Biowissenschaften

Inhaltsverzeichnis

1. Nanofibers: Principles, technology, and current applications in cancer and inflammatory
diseases
Guru Prasanna Sahoo, Jitu Halder, Biswakanth Kar, Goutam Ghosh and Goutam Rath
2. Nanofiber-based drug delivery systems for cancer treatment
Devyani Rajput, Shivangi Sharma, Monika Vishwakarma and Neeraj Mishra
3. Biodegradable polymeric nanofiber—mediated drug delivery approach for localized cancer chemotherapy
Aakanchha Jain
4. Stimuli-responsive implantable biodegradable nanofibers for cancer therapy: challenges and opportunities
Arpana Purohit, Monika Vishwakarma, Tanweer Haider and Vandana Soni
5. Opportunity and challenges in nanofiber technology to target stem and immunocompetent cells for cancer treatment
Manish Kumar, Rupesh K. Gautam, Anchal Mishra, Sumaya Hussain and Mohammad Amjad Kamal
6. Applications of self-assembled peptide nanofibers in cancer immunotherapy
Deepshi Arora, Moin Jahangir, Manish Kumar and Rupesh K. Gautam
7. Biomimetic nanofiber scaffolds for tissue engineering in cancer inflammation
Jitu Halder, Ajit Mishra, Debalina Maity, Biswakanth Kar, Goutam Ghosh and Goutam Rath
8. Nanofiber-based diagnostics for cancer inflammation
Jasmine Kaur, Abhishek Konar, Pranabesh Ghosh, Mukul Barwant and Pooja Kadyan
9. Emerging roles of 3D nanofiber scaffold in targeted cancer therapy and diagnosis
Neeraj Patel, Riya Mishra, Wasim Akram and Tanweer Haider
10. Nanofiber dressings: Curbing inflammation in chronic wound
Saeema Farooq, Danish Ahmad Shergujri, Jasreen Uppal, Apporva Chawla, Roohi Mohi Ud Din and Reyaz Hassan Mir
11. Nanofibers in immunomodulation
Navidha Aggarwal, Tamnna, Parina Kumari, Hitesh Chopra and Mohammad Amjad Kamal
12. Recent advances in bioinspired polymeric nanofiber for the treatment of inflammatory diseases
Garima Sahu, Mukul Maurya, Himanshu Pandey and Shanti Bhushan Mishra
13. Engineered nanofiber scaffold in periodontal regenerative treatment
Prayaga Rajappan Krishnendu, Bahuleyan Jayalakshmy, Jayalakshmi Jayan and Subin Mary Zachariah
14. A clinical and industrial perspective of biodegradable nanofibers in cancer chemotherapy and regenerative medicine
Sarjana Raikwar, Nikhar Vishwakarma, Shatakshi Chourasia, Satish Rojekar and Sanjay K. Jain

Über Autor(innen)

Mishra, Neeraj
Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, India. His academic work focuses on novel drug delivery systems, including localized, targeted, and controlled delivery approaches using nanocarrier and microparticle-based technologies. His research interests encompass therapies for cancer and neurodegenerative disorders, and he has extensive experience in teaching, research supervision, and scholarly publishing. He has also contributed to innovation in pharmaceutical sciences through intellectual property development and collaborative academic activities. Through his research and educational initiatives, he supports the advancement of drug delivery strategies and pharmaceutical research.

Singh, Arun Kumar
Arun Kumar Singh is Assistant Professor in the Department of Pharmacy at the University School of Pharmaceutical Sciences, Rayat Bahra University, Sahauran, India. His research interests include nano-formulation, cancer biology, and neuroscience, alongside digital and computational approaches such as machine learning, artificial intelligence, big data analytics, blockchain, and the Internet of Things. He has contributed academic books, book chapters, and review articles in pharmaceutical sciences and healthcare technology, with a focus on interdisciplinary approaches that integrate pharmaceutical research with emerging digital technologies.

Rath, Goutam
Goutam Rath is Professor in the Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan, Bhubaneswar, India. His research focuses on nanotechnology-based systems for targeted drug and bioactive delivery, with applications in pharmaceutical development and healthcare. Prof. Rath has published extensively in peer-reviewed journals and has contributed to textbooks and book chapters in the fields of pharmaceutics and nanomedicine. His research has resulted in multiple patents, several of which have been transferred for commercial application. He supervises M.Pharm and Ph.D. researchers and serves on national expert panels and advisory groups related to biotechnology, nanomedicine, and pharmaceutical innovation.